MedTrace Logo

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

NCT00203814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2006-11-16

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine alone in the treatment of uncomplicated malaria.

Conditions

Interventions

DRUG

Sulfadoxine-pyrimethamine

DRUG

Artesunate plus sulfadoxine-pyrimethamine

Sponsors & Collaborators

  • World Health Organization

    collaborator OTHER

  • Medical Research Council, South Africa

    collaborator OTHER

  • University of Cape Town

    lead OTHER

Principal Investigators

  • Karen Barnes, MBChB · University of Cape Town

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2005-03-31

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203814 on ClinicalTrials.gov